Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bryce E. Carter"'
Autor:
R. Lor Randall, Angelica R. Putnam, Elizabeth A. Schackmann, James F. Amatruda, Xiaomeng Huang, Heinrich Kovar, Christian N. Paxton, Jamie D. Gardiner, Joshua D. Schiffman, Lisa M. Abegglen, Marcus Stucki, Bryce E. Carter, Stephen L. Lessnick
Publikováno v:
Oncotarget
Oncotarget, vol 8, iss 16
Oncotarget, vol 8, iss 16
CEBPB copy number gain in Ewing sarcoma was previously shown to be associated with worse clinical outcome compared to tumors with normal CEBPB copy number, although the mechanism was not characterized. We employed gene knockdown and rescue assays to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc50a75839a0dd1372c9b284d012b36
https://pubmed.ncbi.nlm.nih.gov/28148901
https://pubmed.ncbi.nlm.nih.gov/28148901
Autor:
Angelica R. Putnam, Jamie D. Gardiner, R. Lor Randall, Marcus Stucki, Bryce E. Carter, Elizabeth A. Schackmann, Clinton C. Mason, Stephen L. Lessnick, Heinrich Kovar, Joshua D. Schiffman, Lisa M. Abegglen
Publikováno v:
Cancer Research. 75:483-483
We previously identified increased copies of CEBPB in a subset of Ewing sarcoma (ES) tumors, and this gain was associated with worse clinical outcome. Due to CEBPB's role in cell growth and differentiation, as well as the gene's ability to transform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::965ea715310366ab209b4e35f1c388b6
https://doi.org/10.1158/1538-7445.am2015-483
https://doi.org/10.1158/1538-7445.am2015-483